Abstract:Copper complexes are considered as potential candidates for anticancer therapy and medical applications. In this paper, three new Cu(II) complexes, [Cu(IPY)2](ClO4)2·H2O (CuI1), [Cu(IPY)(L-Phe)H2O]ClO4·0.5H2O (CuI2) and [Cu(IPY)(L-Val)H2O]ClO4 (CuI3) (where IPY = 2-(1H-imidazol-2-yl)pyridine, L-Phe = L-phenylalanine, L-Val = L-valine), with good amphipathic properties were synthesized and characterized. The single crystal X-ray diffraction results revealed that CuI1 was four-coordinated, while CuI2 and CuI3 both adopted a five-coordinated tetragonal pyramidal configuration. Multi-spectral methods, viscosity experiment and molecular docking technique showed that three complexes interacted with DNA through insertion. The results of the gel electrophoresis experiments indicated that DNA was oxidatively cleaved by all the complexes in a concentration-dependent manner. Moreover, singlet oxygen (1O2), hydrogen peroxide (H2O2) and superoxide anion radicals (·O2−) were associated with oxidative cleavage of DNA. All the complexes also had good binding affinity with human serum albumin (HSA). The MB degradation assay revealed that all complexes could react with H2O2 to form ·OH through Fenton-like processes. The complexes displayed good antiproliferative activity against the tested human cancer cells in vitro, including cervical carcinoma cells (HeLa), liver cancer cells (HepG2 and BEL-7402) and gastric adenocarcinoma cells (SGC-7901), but showed lower toxicity to normal liver cells (LO2). The anticancer mechanism research revealed that CuI1, CuI2 and CuI3 arrested the cell cycle at S phase, elevated intracellular reactive oxygen species (ROS) levels and induced loss of mitochondrial membrane potential (MMP). The results indicated that these Cu(II) complexes could induce DNA damage and ROS-mediated mitochondrial dysfunction, leading to cancer cell apoptosis. Our work provided a theoretical basis for the design of new low-toxic and highly efficient anticancer Cu(II) complexes by incorporating biological metabolites and aromatic heterocycle ligands.

Synthesis, Characterization, DNA Binding Ability and Cytotoxicity of the Novel Platinum(ii), Copper(ii), Cobalt(ii) and Nickel(ii) Complexes with 3-(1H-benzo[d]imidazol-2-yl)-β-carboline

Synthesis, characterization, and cytotoxicity of new types of binuclear platinum(II) complexes

Synthesis, cytotoxicity and DNA binding of novel Ni(II), Co(II) and Zn(II) complexes bearing pyrimidinyl hydrazone ligand

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

Synthesis, characterization, crystal structure, and biological activities of transition metal complexes with 1-phenyl-3-methyl-5-hydroxypyrazole-4- methylene-8′-quinolineimine

Synthesis, Cytotoxicity and DNA Binding Levels of Tri-Functional Mononuclear Platinum(ii) Complexes

Synthesis, crystal structures and anticancer studies of Ni (II), Co (III) and Zn (II) complexes based on 5-bromosalicylaldehyde- 2-(2-aminophenyl)benzimidazole Schiff base

Synthesis, Cytotoxicity and DNA-binding Levels of New Type Binuclear Platinum(ii) Complexes

Synthesis and Biological Activities of Metal Complexes with Schiff Base Ligand Derived from Imidazole-2-Carboxaldehyde and Ethylenediamine

Synthesis, Crystal Structure, Dna Interaction And Antitumor Activity Of Nickel(Ii) Complex With Quinoline-2-Carboxaldehyde N-4-Methyl-Thiosemicarbazone

DNA Binding and in Vitro Anticarcinogenic Activity of a Series of Newfashioned Cu(II)-complexes Based on Tricationic Metalloporphyrin Salicyloylhydrazone Ligands.

Synthesis, structure and anticancer studies of Cu (II), Ni (II) and Co (II) complexes based on 2,3-dihydroxybenzaldehyde-2-(2-aminophenyl)benzimidazole Schiff base

Synthesis,Structure and Anticancer Activity of Binuclear Polypyridine Nickel Complexes

Synthesis, Characterization and Antitumor Activity of New Type Binuclear Platinum(ii) Complexes.

Synthesis, Antiproliferative Activity and Dna Binding Study of Mixed Ammine/Cyclohexylamine Platinum(Ii) Complexes with 1-(Substituted Benzyl) Azetidine-3, 3-Dicarboxylates

Synthesis, DNA-binding, molecular docking and cytotoxic activity in vitro evaluation of ruthenium(II) complexes

Synthesis, Characterization, Investigation of DNA Interactions and Biological Evaluation of Co(II), Ni(II), Cu(II) and Zn(II) Complexes with Newly Synthesized 2-methoxy 5-trifluoromethyl benzenamine Schiff Base

Synthesis, Crystal Structures and Dna-Binding Properties of Cd(Ii), Cu(Ii) and Ni(Ii) Complexes with 2-(2-Pyridyl)benzothiazole

Synthesis, invitro Cytotoxicity, and Interaction with DNA of Platinum(II) Complexes with N-Monocycloalkyl Derivatives of 1R,2R-Diaminocyclohexane as Carrier Ligands

Synthesis, DNA interaction and anticancer activity of copper(II) complexes with 4'-phenyl-2,2':6',2″-terpyridine derivatives.

Synthesis, structure, and biological properties of Cu(II) complexes based on diimine ligands